M 138 M 138 (Stavudine 40 mg)

Pill imprint M 138 M 138 has been identified as Stavudine 40 mg.

Stavudine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Stavudine 40 mg is not a controlled substance under the Controlled Substance Act (CSA).

Stavudine

Imprint:

M 138 M 138

Strength:

40 mg

Color:

Orange

Size:

22.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Nucleoside reverse transcriptase inhibitors (NRTIs)

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-5043

Inactive Ingredients:

lactose anhydrous
magnesium stearate
microcrystalline cellulose
sodium starch glycolate type A potato
D&C Red No. 28
D&C Yellow No. 10
FD&C Yellow No. 6
gelatin
titanium dioxide
ferrosoferric oxide
potassium hydroxide
propylene glycol
shellac

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
54569-6123	A-S Medication Solutions, LLC (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.